American International Group Inc. Sells 5,375 Shares of Stericycle, Inc. (NASDAQ:SRCL)

American International Group Inc. reduced its stake in Stericycle, Inc. (NASDAQ:SRCL) by 4.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 124,974 shares of the business services provider’s stock after selling 5,375 shares during the period. American International Group Inc. owned 0.14% of Stericycle worth $6,194,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the stock. Sei Investments Co. raised its stake in Stericycle by 35.5% in the fourth quarter. Sei Investments Co. now owns 1,061,369 shares of the business services provider’s stock worth $52,601,000 after buying an additional 277,896 shares in the last quarter. Natixis Investment Managers International grew its holdings in Stericycle by 23.6% in the fourth quarter. Natixis Investment Managers International now owns 3,207 shares of the business services provider’s stock worth $159,000 after purchasing an additional 612 shares during the period. Thematics Asset Management grew its holdings in Stericycle by 15.1% in the fourth quarter. Thematics Asset Management now owns 492,471 shares of the business services provider’s stock worth $24,407,000 after purchasing an additional 64,471 shares during the period. Schroder Investment Management Group grew its holdings in Stericycle by 8.1% in the fourth quarter. Schroder Investment Management Group now owns 1,739,644 shares of the business services provider’s stock worth $86,217,000 after purchasing an additional 129,822 shares during the period. Finally, Pinebridge Investments L.P. grew its holdings in Stericycle by 51.4% in the fourth quarter. Pinebridge Investments L.P. now owns 20,904 shares of the business services provider’s stock worth $1,036,000 after purchasing an additional 7,097 shares during the period. 98.82% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on SRCL. Robert W. Baird cut their price objective on shares of Stericycle from $62.00 to $55.00 and set a “neutral” rating on the stock in a report on Friday, April 26th. Stifel Nicolaus upped their price objective on shares of Stericycle from $70.00 to $75.00 and gave the stock a “buy” rating in a report on Thursday, February 29th. StockNews.com began coverage on shares of Stericycle in a report on Friday. They issued a “hold” rating on the stock. Truist Financial upped their price objective on shares of Stericycle from $50.00 to $62.00 and gave the stock a “hold” rating in a report on Tuesday, June 4th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and set a $62.00 price target (down previously from $69.00) on shares of Stericycle in a report on Tuesday, June 4th. One analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $74.00.

Stericycle Trading Down 0.3 %

NASDAQ:SRCL opened at $57.56 on Friday. The stock has a market cap of $5.34 billion, a price-to-earnings ratio of -261.64, a PEG ratio of 3.15 and a beta of 1.08. The company’s 50 day moving average price is $50.92 and its 200-day moving average price is $50.46. Stericycle, Inc. has a 52 week low of $37.78 and a 52 week high of $59.45. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.55.

Stericycle (NASDAQ:SRCL) last issued its quarterly earnings data on Thursday, April 25th. The business services provider reported $0.57 earnings per share for the quarter, beating analysts’ consensus estimates of $0.54 by $0.03. The company had revenue of $664.90 million for the quarter, compared to the consensus estimate of $676.42 million. Stericycle had a negative net margin of 0.74% and a positive return on equity of 7.31%. The firm’s revenue for the quarter was down 2.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.49 earnings per share. On average, equities research analysts forecast that Stericycle, Inc. will post 2.32 earnings per share for the current fiscal year.

Stericycle Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.